Global Point-Of-Care Or Rapid Diagnostics Market Growth 2022-2028
As the global economy mends, the 2021 growth of Point-Of-Care Or Rapid Diagnostics will have significant change from previous year. According to our latest study, the global Point-Of-Care Or Rapid Diagnostics market size is USD million in 2022 from USD 25110 million in 2021, with a change of % between 2021 and 2022. The global Point-Of-Care Or Rapid Diagnostics market size will reach USD 48170 million in 2028, growing at a CAGR of 9.8% over the analysis period.
The United States Point-Of-Care Or Rapid Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Point-Of-Care Or Rapid Diagnostics market, reaching US$ million by the year 2028. As for the Europe Point-Of-Care Or Rapid Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Point-Of-Care Or Rapid Diagnostics players cover Roche, Abbott, Danaher, and Siemens Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-Of-Care Or Rapid Diagnostics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intensive Care
Covid-19 Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Independent Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Roche
Abbott
Danaher
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Thermo Fisher Scientific
Quidel
A. Menarini Diagnostics
Becton Dickinson
Biosurfit
Astrego Diagnostics
Werfen
Abionic
Palex Medical/Bülhmann
Horiba Medical
RAL
Vircell
Monlab
Binding Site
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Country/Region, 2017, 2022 & 2028
2.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
2.2.1 Intensive Care
2.2.2 Covid-19 Testing
2.2.3 Infectious Diseases Testing
2.2.4 Cardiac Markers Testing
2.2.5 Coagulation Testing
2.2.6 Others
2.3 Point-Of-Care Or Rapid Diagnostics Sales by Type
2.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
2.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2017-2022)
2.4 Point-Of-Care Or Rapid Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Independent Laboratories
2.4.4 Others
2.5 Point-Of-Care Or Rapid Diagnostics Sales by Application
2.5.1 Global Point-Of-Care Or Rapid Diagnostics Sale Market Share by Application (2017-2022)
2.5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2017-2022)
3 Global Point-Of-Care Or Rapid Diagnostics by Company
3.1 Global Point-Of-Care Or Rapid Diagnostics Breakdown Data by Company
3.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Company (2020-2022)
3.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2020-2022)
3.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Company (2020-2022)
3.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2020-2022)
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2020-2022)
3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company
3.4 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Product Location Distribution
3.4.2 Players Point-Of-Care Or Rapid Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
4.1 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Geographic Region (2017-2022)
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Geographic Region
4.2 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Country/Region (2017-2022)
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Country/Region
4.3 Americas Point-Of-Care Or Rapid Diagnostics Sales Growth
4.4 APAC Point-Of-Care Or Rapid Diagnostics Sales Growth
4.5 Europe Point-Of-Care Or Rapid Diagnostics Sales Growth
4.6 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Growth
5 Americas
5.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country
5.1.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022)
5.1.2 Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022)
5.2 Americas Point-Of-Care Or Rapid Diagnostics Sales by Type
5.3 Americas Point-Of-Care Or Rapid Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region
6.1.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2017-2022)
6.1.2 APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2017-2022)
6.2 APAC Point-Of-Care Or Rapid Diagnostics Sales by Type
6.3 APAC Point-Of-Care Or Rapid Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Point-Of-Care Or Rapid Diagnostics by Country
7.1.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022)
7.1.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022)
7.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Type
7.3 Europe Point-Of-Care Or Rapid Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics by Country
8.1.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022)
8.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type
8.3 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-Of-Care Or Rapid Diagnostics
10.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
10.4 Industry Chain Structure of Point-Of-Care Or Rapid Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-Of-Care Or Rapid Diagnostics Distributors
11.3 Point-Of-Care Or Rapid Diagnostics Customer
12 World Forecast Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
12.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Region
12.1.1 Global Point-Of-Care Or Rapid Diagnostics Forecast by Region (2023-2028)
12.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-Of-Care Or Rapid Diagnostics Forecast by Type
12.7 Global Point-Of-Care Or Rapid Diagnostics Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-Of-Care Or Rapid Diagnostics Product Offered
13.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Point-Of-Care Or Rapid Diagnostics Product Offered
13.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Point-Of-Care Or Rapid Diagnostics Product Offered
13.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Offered
13.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Information
13.5.2 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Offered
13.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bio-Rad Laboratories Main Business Overview
13.5.5 Bio-Rad Laboratories Latest Developments
13.6 BioMerieux
13.6.1 BioMerieux Company Information
13.6.2 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Offered
13.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BioMerieux Main Business Overview
13.6.5 BioMerieux Latest Developments
13.7 Nova Biomedical
13.7.1 Nova Biomedical Company Information
13.7.2 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Offered
13.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nova Biomedical Main Business Overview
13.7.5 Nova Biomedical Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Offered
13.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 Quidel
13.9.1 Quidel Company Information
13.9.2 Quidel Point-Of-Care Or Rapid Diagnostics Product Offered
13.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Quidel Main Business Overview
13.9.5 Quidel Latest Developments
13.10 A. Menarini Diagnostics
13.10.1 A. Menarini Diagnostics Company Information
13.10.2 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Offered
13.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 A. Menarini Diagnostics Main Business Overview
13.10.5 A. Menarini Diagnostics Latest Developments
13.11 Becton Dickinson
13.11.1 Becton Dickinson Company Information
13.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Offered
13.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Becton Dickinson Main Business Overview
13.11.5 Becton Dickinson Latest Developments
13.12 Biosurfit
13.12.1 Biosurfit Company Information
13.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Offered
13.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biosurfit Main Business Overview
13.12.5 Biosurfit Latest Developments
13.13 Astrego Diagnostics
13.13.1 Astrego Diagnostics Company Information
13.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Offered
13.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Astrego Diagnostics Main Business Overview
13.13.5 Astrego Diagnostics Latest Developments
13.14 Werfen
13.14.1 Werfen Company Information
13.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Product Offered
13.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Werfen Main Business Overview
13.14.5 Werfen Latest Developments
13.15 Abionic
13.15.1 Abionic Company Information
13.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Product Offered
13.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Abionic Main Business Overview
13.15.5 Abionic Latest Developments
13.16 Palex Medical/Bülhmann
13.16.1 Palex Medical/Bülhmann Company Information
13.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Offered
13.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Palex Medical/Bülhmann Main Business Overview
13.16.5 Palex Medical/Bülhmann Latest Developments
13.17 Horiba Medical
13.17.1 Horiba Medical Company Information
13.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Offered
13.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Horiba Medical Main Business Overview
13.17.5 Horiba Medical Latest Developments
13.18 RAL
13.18.1 RAL Company Information
13.18.2 RAL Point-Of-Care Or Rapid Diagnostics Product Offered
13.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 RAL Main Business Overview
13.18.5 RAL Latest Developments
13.19 Vircell
13.19.1 Vircell Company Information
13.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Product Offered
13.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Vircell Main Business Overview
13.19.5 Vircell Latest Developments
13.20 Monlab
13.20.1 Monlab Company Information
13.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Product Offered
13.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Monlab Main Business Overview
13.20.5 Monlab Latest Developments
13.21 Binding Site
13.21.1 Binding Site Company Information
13.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Product Offered
13.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Binding Site Main Business Overview
13.21.5 Binding Site Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intensive Care
Table 4. Major Players of Covid-19 Testing
Table 5. Major Players of Infectious Diseases Testing
Table 6. Major Players of Cardiac Markers Testing
Table 7. Major Players of Coagulation Testing
Table 8. Major Players of Others
Table 9. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2017-2022) & (K Doses)
Table 10. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
Table 11. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2017-2022) & ($ million)
Table 12. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2017-2022)
Table 13. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2017-2022) & (US$/Dose)
Table 14. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2017-2022) & (K Doses)
Table 15. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Table 16. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2017-2022)
Table 17. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2017-2022)
Table 18. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2017-2022) & (US$/Dose)
Table 19. Global Point-Of-Care Or Rapid Diagnostics Sales by Company (2020-2022) & (K Doses)
Table 20. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2020-2022)
Table 21. Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2020-2022)
Table 23. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company (2020-2022) & (US$/Dose)
Table 24. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution and Sales Area
Table 25. Players Point-Of-Care Or Rapid Diagnostics Products Offered
Table 26. Point-Of-Care Or Rapid Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Point-Of-Care Or Rapid Diagnostics Sales by Geographic Region (2017-2022) & (K Doses)
Table 30. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Geographic Region (2017-2022)
Table 31. Global Point-Of-Care Or Rapid Diagnostics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Point-Of-Care Or Rapid Diagnostics Sales by Country/Region (2017-2022) & (K Doses)
Table 34. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country/Region (2017-2022)
Table 35. Global Point-Of-Care Or Rapid Diagnostics Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022) & (K Doses)
Table 38. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2017-2022)
Table 39. Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2017-2022)
Table 41. Americas Point-Of-Care Or Rapid Diagnostics Sales by Type (2017-2022) & (K Doses)
Table 42. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
Table 43. Americas Point-Of-Care Or Rapid Diagnostics Sales by Application (2017-2022) & (K Doses)
Table 44. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Table 45. APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2017-2022) & (K Doses)
Table 46. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2017-2022)
Table 47. APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2017-2022)
Table 49. APAC Point-Of-Care Or Rapid Diagnostics Sales by Type (2017-2022) & (K Doses)
Table 50. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
Table 51. APAC Point-Of-Care Or Rapid Diagnostics Sales by Application (2017-2022) & (K Doses)
Table 52. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Table 53. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022) & (K Doses)
Table 54. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2017-2022)
Table 55. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2017-2022)
Table 57. Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
Table 59. Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2017-2022) & (K Doses)
Table 60. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2017-2022) & (K Doses)
Table 62. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2017-2022) & (K Doses)
Table 66. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2017-2022) & (K Doses)
Table 68. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Point-Of-Care Or Rapid Diagnostics
Table 70. Key Market Challenges & Risks of Point-Of-Care Or Rapid Diagnostics
Table 71. Key Industry Trends of Point-Of-Care Or Rapid Diagnostics
Table 72. Point-Of-Care Or Rapid Diagnostics Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Point-Of-Care Or Rapid Diagnostics Distributors List
Table 75. Point-Of-Care Or Rapid Diagnostics Customer List
Table 76. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2023-2028) & (K Doses)
Table 77. Global Point-Of-Care Or Rapid Diagnostics Sales Market Forecast by Region
Table 78. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2023-2028) & (K Doses)
Table 81. Americas Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2023-2028) & (K Doses)
Table 83. APAC Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2023-2028) & (K Doses)
Table 85. Europe Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2023-2028) & (K Doses)
Table 87. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2023-2028) & (K Doses)
Table 89. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2023-2028) & (K Doses)
Table 93. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Application (2023-2028)
Table 96. Roche Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Point-Of-Care Or Rapid Diagnostics Product Offered
Table 98. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. Abbott Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbott Point-Of-Care Or Rapid Diagnostics Product Offered
Table 103. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 104. Abbott Main Business
Table 105. Abbott Latest Developments
Table 106. Danaher Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 107. Danaher Point-Of-Care Or Rapid Diagnostics Product Offered
Table 108. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 109. Danaher Main Business
Table 110. Danaher Latest Developments
Table 111. Siemens Healthcare Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 112. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Offered
Table 113. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 114. Siemens Healthcare Main Business
Table 115. Siemens Healthcare Latest Developments
Table 116. Bio-Rad Laboratories Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 117. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Offered
Table 118. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 119. Bio-Rad Laboratories Main Business
Table 120. Bio-Rad Laboratories Latest Developments
Table 121. BioMerieux Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 122. BioMerieux Point-Of-Care Or Rapid Diagnostics Product Offered
Table 123. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 124. BioMerieux Main Business
Table 125. BioMerieux Latest Developments
Table 126. Nova Biomedical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 127. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Offered
Table 128. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 129. Nova Biomedical Main Business
Table 130. Nova Biomedical Latest Developments
Table 131. Thermo Fisher Scientific Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 132. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Offered
Table 133. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 134. Thermo Fisher Scientific Main Business
Table 135. Thermo Fisher Scientific Latest Developments
Table 136. Quidel Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 137. Quidel Point-Of-Care Or Rapid Diagnostics Product Offered
Table 138. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 139. Quidel Main Business
Table 140. Quidel Latest Developments
Table 141. A. Menarini Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 142. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Offered
Table 143. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 144. A. Menarini Diagnostics Main Business
Table 145. A. Menarini Diagnostics Latest Developments
Table 146. Becton Dickinson Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 147. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Offered
Table 148. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 149. Becton Dickinson Main Business
Table 150. Becton Dickinson Latest Developments
Table 151. Biosurfit Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 152. Biosurfit Point-Of-Care Or Rapid Diagnostics Product Offered
Table 153. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 154. Biosurfit Main Business
Table 155. Biosurfit Latest Developments
Table 156. Astrego Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 157. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Offered
Table 158. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 159. Astrego Diagnostics Main Business
Table 160. Astrego Diagnostics Latest Developments
Table 161. Werfen Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 162. Werfen Point-Of-Care Or Rapid Diagnostics Product Offered
Table 163. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 164. Werfen Main Business
Table 165. Werfen Latest Developments
Table 166. Abionic Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 167. Abionic Point-Of-Care Or Rapid Diagnostics Product Offered
Table 168. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 169. Abionic Main Business
Table 170. Abionic Latest Developments
Table 171. Palex Medical/Bülhmann Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 172. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Offered
Table 173. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 174. Palex Medical/Bülhmann Main Business
Table 175. Palex Medical/Bülhmann Latest Developments
Table 176. Horiba Medical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 177. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Offered
Table 178. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 179. Horiba Medical Main Business
Table 180. Horiba Medical Latest Developments
Table 181. RAL Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 182. RAL Point-Of-Care Or Rapid Diagnostics Product Offered
Table 183. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 184. RAL Main Business
Table 185. RAL Latest Developments
Table 186. Vircell Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 187. Vircell Point-Of-Care Or Rapid Diagnostics Product Offered
Table 188. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 189. Vircell Main Business
Table 190. Vircell Latest Developments
Table 191. Monlab Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 192. Monlab Point-Of-Care Or Rapid Diagnostics Product Offered
Table 193. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 194. Monlab Main Business
Table 195. Monlab Latest Developments
Table 196. Binding Site Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 197. Binding Site Point-Of-Care Or Rapid Diagnostics Product Offered
Table 198. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2020-2022)
Table 199. Binding Site Main Business
Table 200. Binding Site Latest Developments
List of Figures
Figure 1. Picture of Point-Of-Care Or Rapid Diagnostics
Figure 2. Point-Of-Care Or Rapid Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2017-2028 (K Doses)
Figure 7. Global Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Point-Of-Care Or Rapid Diagnostics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intensive Care
Figure 10. Product Picture of Covid-19 Testing
Figure 11. Product Picture of Infectious Diseases Testing
Figure 12. Product Picture of Cardiac Markers Testing
Figure 13. Product Picture of Coagulation Testing
Figure 14. Product Picture of Others
Figure 15. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type in 2021
Figure 16. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2017-2022)
Figure 17. Point-Of-Care Or Rapid Diagnostics Consumed in Hospital
Figure 18. Global Point-Of-Care Or Rapid Diagnostics Market: Hospital (2017-2022) & (K Doses)
Figure 19. Point-Of-Care Or Rapid Diagnostics Consumed in Clinic
Figure 20. Global Point-Of-Care Or Rapid Diagnostics Market: Clinic (2017-2022) & (K Doses)
Figure 21. Point-Of-Care Or Rapid Diagnostics Consumed in Independent Laboratories
Figure 22. Global Point-Of-Care Or Rapid Diagnostics Market: Independent Laboratories (2017-2022) & (K Doses)
Figure 23. Point-Of-Care Or Rapid Diagnostics Consumed in Others
Figure 24. Global Point-Of-Care Or Rapid Diagnostics Market: Others (2017-2022) & (K Doses)
Figure 25. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2017-2022)
Figure 26. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application in 2021
Figure 27. Point-Of-Care Or Rapid Diagnostics Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company in 2021
Figure 29. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Geographic Region in 2021
Figure 31. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2017-2022)
Figure 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country/Region in 2021
Figure 33. Americas Point-Of-Care Or Rapid Diagnostics Sales 2017-2022 (K Doses)
Figure 34. Americas Point-Of-Care Or Rapid Diagnostics Revenue 2017-2022 ($ Millions)
Figure 35. APAC Point-Of-Care Or Rapid Diagnostics Sales 2017-2022 (K Doses)
Figure 36. APAC Point-Of-Care Or Rapid Diagnostics Revenue 2017-2022 ($ Millions)
Figure 37. Europe Point-Of-Care Or Rapid Diagnostics Sales 2017-2022 (K Doses)
Figure 38. Europe Point-Of-Care Or Rapid Diagnostics Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales 2017-2022 (K Doses)
Figure 40. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue 2017-2022 ($ Millions)
Figure 41. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2021
Figure 42. Americas Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2021
Figure 43. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2021
Figure 48. APAC Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Regions in 2021
Figure 49. China Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2021
Figure 56. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2021
Figure 57. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2021
Figure 64. Egypt Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Point-Of-Care Or Rapid Diagnostics Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Point-Of-Care Or Rapid Diagnostics in 2021
Figure 70. Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
Figure 71. Industry Chain Structure of Point-Of-Care Or Rapid Diagnostics
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
